Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type description Interaction Map Rank Gene Network Comparison Type Filtered green red network_comparison
Results: HTML CSV LaTeX Showing element 744 to 793 of 3228 in total 
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
deformed epidermal autoregulatory factor 1 homolog (nuclear deaf-1 related transcriptional regulator) (nudr) (suppressin) (zinc finger mynd domain containing protein 5). [source:swissprot;acc:o75398]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2584\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4253.46\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4180.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0175\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
dehydrodolichyl diphosphate synthase. [source:refseq;acc:nm\_024887]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1280\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6874.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6350.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08252\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
delta 1-pyrroline-5-carboxylate synthetase (p5cs) [includes: glutamate 5-kinase (ec 2.7.2.11) (gamma-glutamyl kinase) (gk); gamma-glutamyl phosphate reductase (gpr) (ec 1.2.1.41) (glutamate-5-semialdehyde dehydrogenase) (glutamyl-gamma-semialdehyde dehydrogenase)]. [source:swissprot;acc:p54886]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1488\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5991.58\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5573.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07499\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
delta(14)-sterol reductase (ec 1.3.1.70) (c-14 sterol reductase) (sterol c14-reductase) (delta14-sr) (transmembrane 7 superfamily member 2) (another new gene 1) (putative sterol reductase sr-1). [source:swissprot;acc:o76062]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2309\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7273.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6960.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04493\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
delta-aminolevulinic acid dehydratase (ec 4.2.1.24) (porphobilinogen synthase) (aladh). [source:swissprot;acc:p13716]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1158\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5972.09\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5489.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08797\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
delta-interacting protein a (hepatitis delta antigen interacting protein a). [source:swissprot;acc:q15834]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1410\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6760.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6274.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07748\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
delta-sarcoglycan (sg-delta) (35 kda dystrophin-associated glycoprotein) (35dag). [source:swissprot;acc:q92629]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
738\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6434.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5768.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11554\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
delta3,5-delta2,4-dienoyl-coa isomerase, mitochondrial precursor (ec 5.3.3.-). [source:swissprot;acc:q13011]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1019\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6340.86\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5791.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0948\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
deltex 2. [source:refseq;acc:nm\_020892]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
54\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2651.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1618.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.63814\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
deltex homolog 1; hdx-1. [source:refseq;acc:nm\_004416]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
55\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
2662.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1629.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.63399\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
dendritic cell protein. [source:refseq;acc:nm\_006360]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
715\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7364.55\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6593.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.117\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
density-regulated protein (drp) (drp1 protein) (smooth muscle cell associated protein-3) (smap-3). [source:swissprot;acc:o43583]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1589\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3360.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3600.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07162\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
deoxycytidylate deaminase (ec 3.5.4.12) (dcmp deaminase). [source:swissprot;acc:p32321]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2148\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4892.06\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4644.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05328\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
deoxyhypusine synthase (ec 2.5.1.46) (dhs). [source:swissprot;acc:p49366]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1493\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6606.21\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6146.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07482\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
deoxyribonuclease ii beta isoform 1 precursor; deoxyribonuclease ii beta; endonuclease dlad. [source:refseq;acc:nm\_021233]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
324\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
33457.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
28136.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.18912\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial precursor (ec 3.6.1.23) (dutpase) (dutp pyrophosphatase). [source:swissprot;acc:p33316]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
567\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9043.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10264.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13506\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
destrin (actin-depolymerizing factor) (adf). [source:swissprot;acc:p18282]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1948\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6608.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6230.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06074\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
developmentally regulated gtp-binding protein 1 (drg 1). [source:swissprot;acc:q9y295]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2762\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
developmentally regulated gtp-binding protein 2 (drg 2). [source:swissprot;acc:p55039]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3092\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
dgcr14 protein (digeorge syndrome critical region 14) (es2 protein). [source:swissprot;acc:q96df8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
17\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1365\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
460\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.96739\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
dgcr8 protein (digeorge syndrome critical region 8). [source:swissprot;acc:q8wyq5]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3006\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
di-ras2. [source:refseq;acc:nm\_017594]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
706\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7734.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6912.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11897\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
dihydrofolate reductase (ec 1.5.1.3). [source:swissprot;acc:p00374]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1803\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5307.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4980.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06571\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial precursor (ec 2.3.1.12) (e2) (pdc-e2) (70 kda mitochondrial autoantigen of primary biliary cirrhosis) (pbc) (m2 antigen complex 70 kda subunit). [source:swissprot;acc:p10515]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2464\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6486.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6291.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03098\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
dihydrolipoamide dehydrogenase, mitochondrial precursor (ec 1.8.1.4) (glycine cleavage system l protein). [source:swissprot;acc:p09622]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2600\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6283.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6185\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01597\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial precursor (ec 2.3.1.61) (e2) (e2k). [source:swissprot;acc:p36957]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2535\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6603.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6452.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0235\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
dihydroorotate dehydrogenase, mitochondrial precursor (ec 1.3.3.1) (dihydroorotate oxidase) (dhodehase) (fragment). [source:swissprot;acc:q02127]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
830\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6354.75\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5745.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10602\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
dihydropyrimidine dehydrogenase [nadp+] precursor (ec 1.3.1.2) (dpd) (dhpdhase) (dihydrouracil dehydrogenase) (dihydrothymine dehydrogenase). [source:swissprot;acc:q12882]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
714\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5834.57\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5222.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11715\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
dimeric dihydrodiol dehydrogenase; 3-deoxyglucosone reductase. [source:refseq;acc:nm\_014475]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1629\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6590.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6158.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07026\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 1 (ec 1.14.13.8) (fetal hepatic flavin-containing monooxygenase 1) (fmo 1) (dimethylaniline oxidase 1). [source:swissprot;acc:q01740]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
975\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5884.43\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5365.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09679\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 2 (ec 1.14.13.8) (pulmonary flavin-containing monooxygenase 2) (fmo 2) (dimethylaniline oxidase 2) (fmo 1b1). [source:swissprot;acc:q99518]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
974\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5884.52\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5365.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09682\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 3 (ec 1.14.13.8) (hepatic flavin-containing monooxygenase 3) (fmo 3) (dimethylaniline oxidase 3) (fmo form 2) (fmo ii). [source:swissprot;acc:p31513]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
956\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5884.89\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5364.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09695\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 4 (ec 1.14.13.8) (hepatic flavin-containing monooxygenase 4) (fmo 4) (dimethylaniline oxidase 4). [source:swissprot;acc:p31512]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
976\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5884.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5365.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09675\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
dimethylaniline monooxygenase [n-oxide forming] 5 (ec 1.14.13.8) (hepatic flavin-containing monooxygenase 5) (fmo 5) (dimethylaniline oxidase 5). [source:swissprot;acc:p49326]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
951\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5885.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5364.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09716\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
dipeptidyl aminopeptidase-like protein 6 (dipeptidylpeptidase vi) (dipeptidylpeptidase 6) (dipeptidyl peptidase iv like protein) (dipeptidyl aminopeptidase-related protein) (dppx). [source:swissprot;acc:p42658]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
930\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6194.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5638.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09853\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
dipeptidyl peptidase 8 isoform 2; dipeptidyl peptidase 8. [source:refseq;acc:nm\_017743]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2669\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4310.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4336.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0061\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
dipeptidylpeptidase 10; dipeptidyl peptidase iv-related protein 3. [source:refseq;acc:nm\_020868]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
927\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6194.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5638.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09853\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
dipeptidylpeptidase 9; dipeptidyl peptidase 9; dipeptidyl peptidase iv-related protein-2. [source:refseq;acc:nm\_139159]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2670\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4310.35\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4336.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00609\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
diphosphomevalonate decarboxylase (ec 4.1.1.33) (mevalonate pyrophosphate decarboxylase) (mevalonate (diphospho)decarboxylase). [source:swissprot;acc:p53602]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2388\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4594.87\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4418.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03998\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
diphthamide biosynthesis-like protein 2. [source:refseq;acc:nm\_001384]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2020\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5224.27\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4935.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05844\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
disks large-associated protein 1 (dap-1) (guanylate kinase-associated protein) (hgkap) (sap90/psd-95-associated protein 1) (sapap1) (psd- 95/sap90 binding protein 1). [source:swissprot;acc:o14490]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
625\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
7013.19\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6228.39\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.126\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
disks large-associated protein 2 (dap-2) (sap90/psd-95-associated protein 2) (sapap2) (psd-95/sap90 binding protein 2) (fragment). [source:swissprot;acc:q9p1a6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
632\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
disks large-associated protein 3 (dap-3) (sap90/psd-95-associated protein 3) (sapap3) (psd-95/sap90 binding protein 3) (fragment). [source:swissprot;acc:o95886]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
630\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
disks large-associated protein 4 (dap-4) (sap90/psd-95-associated protein 4) (sapap4) (psd-95/sap90 binding protein 4). [source:swissprot;acc:q9y2h0]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
634\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
disrupter of silencing 10. [source:refseq;acc:nm\_020368]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2313\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7273.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6960.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.04493\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
dj1099d15.1 (putative dnaj protein). [source:sptrembl;acc:q9h4j9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
655\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4593.43\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4088.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12346\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
dj132f21.2 (contains a novel protein similar to the l82e from drosophila) (fragment). [source:sptrembl;acc:q9h125]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2145\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6173.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5859.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05369\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
dj153g14.2 (possible ca binding protein similar to nefa) (fragment). [source:sptrembl;acc:q9ujn8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
899\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6531.52\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5929.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10152\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
dj18d14.4 (cytochrome p450, subfamily iva, polypeptide 11). [source:sptrembl;acc:q9ntl5]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1293\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6120.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5655.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08218\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
dj408b20.3 (novel protein similar to 60s acidic ribosomal protein p2 (rplp2)). [source:sptrembl;acc:q9h5a9]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2662\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4334.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4300.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00795\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/